Understanding complicated infections in ear, nose, and throat

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the management of complicated infections treated by otorhinolaryngologists in Ljubljana, Slovenia. It aims to gather data on the treatment of conditions such as sinusitis, otitis, laryngitis, lymphadenitis, and quinsy, with the goal of improving treatment outcomes and reducing hospitalization times. Participants will receive standard evidence-based treatment, and the study will establish a database for ongoing analysis of these infections in the ENT field. The findings will help create clinical pathways for better management of these diseases in Slovenia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnoses: rhinitis AND/OR sinusitis AND/OR facial cellulitis AND/OR facial abscess AND/OR nasal furuncle AND/OR infection of the outer AND/OR middle AND/OR inner ear AND/OR temporal bone AND/OR infection of the soft tissues of the neck with/without bone and cartilage involvement AND/OR laryngitis AND/OR epiglottitis (or supraglottitis) AND/OR
* complication of inflammation of the nose and paranasal cavities AND/OR ear AND/OR temporal bone AND/OR:
* treated at the Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Center Ljubljana.

Exclusion Criteria:

* disagreement of the patient and/or parents (or legal guardians) with inclusion in the research,
* failure to meet the inclusion criteria.

Where it's running

• University Medical Centre Ljubljana
  Ljubljana, Ljubljana, Slovenia Recruiting

Study contacts

• Principal investigator: Domen Vozel, MD, PhD — Department of Otorhinolaryngology and Cervicofacial Surgery, UMC Ljubljana
• Study coordinator: Domen Vozel, MD, PhD
• Email: domen.vozel@kclj.si
• Phone: +38615223280

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-time IV penicillin added to standard penicillin for adults with acute tonsillitis, tonsillitis with peritonsillar phlegmon, or peritonsillar abscess

  A single dose of intravenous benzylpenicillin is given alongside standard oral penicillin to adults with acute tonsillitis, peritonsillar phlegmon, or peritonsillar abscess to see if symptoms improve.

  Recruiting Phase 4 Aarhus University Hospital · Aarhus, Central Jutland · NCT07896226

• Which antibiotic works best for kids with sinus infections?

  This study tests whether amoxicillin, amoxicillin-clavulanate, or a placebo help children with acute sinusitis feel better faster.

  Recruiting Phase 4 University of Pittsburgh · Denver, Colorado and 4 other locations · NCT07732699

• Transoral ultrasound versus standard clinical exam to diagnose peritonsillar abscess

  This trial will test whether adding transoral ultrasound helps doctors tell which adults with suspected peritonsillar abscess need drainage.

  Recruiting at 2 sites Copenhagen University Hospital, Rigshospitalet · Copenhagen and 2 other locations · NCT07577232

• Stop antibiotics early when symptoms stop in kids after IV treatment

  This trial tests whether stopping oral antibiotics as soon as symptoms disappear is just as effective as finishing the prescribed course for kids who had IV antibiotics for cellulitis, UTI, LRTI, or lymphadenitis.

  Recruiting Phase 4 Murdoch Childrens Research Institute · Melbourne, Victoria · NCT07532941

• Shortening antibiotic courses for common throat and chest infections in primary care with doctor–pharmacist teamwork and viral‑circulation updates

  This project will test whether giving primary care doctors and pharmacists extra information about circulating viruses plus a shared protocol helps shorten antibiotic courses for patients with common respiratory infections.

  Recruiting University Hospital, Caen · Caen · NCT07359287

• Trimethoprim-sulfamethoxazole versus clindamycin for children with invasive MRSA infections

  This will see if trimethoprim-sulfamethoxazole works as well as clindamycin to treat invasive MRSA infections in children aged 60 days to 18 years.

  Recruiting Phase 4 Indiana University · Indianapolis, Indiana · NCT06982105

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.